Joel N. Swerdel

1.1k total citations
36 papers, 518 citations indexed

About

Joel N. Swerdel is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Epidemiology. According to data from OpenAlex, Joel N. Swerdel has authored 36 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Joel N. Swerdel's work include Heart Failure Treatment and Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Joel N. Swerdel is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Joel N. Swerdel collaborates with scholars based in United States, Netherlands and Malaysia. Joel N. Swerdel's co-authors include Andrea A. Seymour, John B. Kostis, Benoni E. Abboa‐Offei, Nora M. Cosgrove, Patrick Ryan, Teresa Janević, George Hripcsak, Norma G. Delaney, Martijn J. Schuemie and Mavis R. Swerdel and has published in prestigious journals such as PLoS ONE, Hypertension and Journal of Nutrition.

In The Last Decade

Joel N. Swerdel

35 papers receiving 497 citations

Peers

Countries citing papers authored by Joel N. Swerdel

Since Specialization

Citations

This map shows the geographic impact of Joel N. Swerdel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel N. Swerdel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel N. Swerdel more than expected).

Fields of papers citing papers by Joel N. Swerdel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel N. Swerdel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel N. Swerdel. The network helps show where Joel N. Swerdel may publish in the future.

Co-authorship network of co-authors of Joel N. Swerdel

This figure shows the co-authorship network connecting the top 25 collaborators of Joel N. Swerdel. A scholar is included among the top collaborators of Joel N. Swerdel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel N. Swerdel. Joel N. Swerdel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Adult Patients With Dermatomyositis Using Real‐World Data Sources 2025 ·Arthritis Care & Research ·(unknown), (unknown), (unknown), Thomas Falconer, Elizabeth Park, (unknown), David Fiorentino, Leland W.K. Chung, (unknown), (unknown), Didem Saygın, Michael George, Gowtham Rao, Joel N. Swerdel, Azza Shoaibi, Christopher A. Mecoli	0
2	Health-Analytics Data to Evidence Suite (HADES): Open-Source Software for Observational Research 2024 ·Studies in health technology and informatics ·Martijn J. Schuemie, Jenna Reps, Adam Black, Frank DeFalco, Lee Evans, Egill A. Friðgeirsson, James P. Gilbert, Chris Knoll, (unknown), Gowtham Rao, Peter R. Rijnbeek, (unknown), Anthony G. Sena, Joel N. Swerdel, Ross D. Williams, Marc A. Suchard	12
3	The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases 2023 ·Advances in Therapy ·Darmendra Ramcharran, Bruce Strober, Kenneth B. Gordon, Cynthia Marie Carver DeKlotz, Steven Fakharzadeh, Ya‐Wen Yang, Joel N. Swerdel, Jill Hardin, (unknown), Amy S. Paller	5
4	Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus 2023 ·PLoS ONE ·Joel N. Swerdel, Darmendra Ramcharran, Jill Hardin	2
5	Development and performance characteristics of novel code‐based algorithms to identify invasive Escherichia coli disease 2022 ·Pharmacoepidemiology and Drug Safety ·(unknown), (unknown), (unknown), Michal Sarnecki, Joel N. Swerdel, (unknown), Jeroen Geurtsen	2
6	Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms’ Fit for Purpose for Safety Outcomes 2022 ·Drug Safety ·Sonal Singh, (unknown), Xiaofeng Zhou, Joel N. Swerdel, Raymond A. Harvey, Kenneth Hornbuckle, Leo Russo, (unknown), (unknown), (unknown), (unknown)	3
7	Phenotype Algorithms to Identify Hidradenitis Suppurativa Using Real-World Data: Development and Validation Study 2022 ·JMIR Dermatology ·Jill Hardin, (unknown), Joel N. Swerdel	2
8	PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation 2022 ·Journal of Biomedical Informatics ·Joel N. Swerdel, Martijn J. Schuemie, (unknown), Patrick Ryan	10
9	Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study 2020 ·Current Medical Research and Opinion ·Žhong Yuan, Frank DeFalco, (unknown), Laura Hester, James Weaver, Joel N. Swerdel, (unknown), Patrick Ryan, Martijn J. Schuemie, R. Qiu, Jacqueline Yee, Gary Meininger, Jesse A. Berlin, Norman Rosenthal	3
10	Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen 2020 ·Drug Safety ·Rachel Weinstein, Patrick Ryan, Jesse A. Berlin, Martijn J. Schuemie, Joel N. Swerdel, Daniel Fife	7
11	Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets 2020 ·Drug Safety ·Joel N. Swerdel, Jenna Reps, Daniel Fife, Patrick Ryan	1
12	Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts 2019 ·Korean Circulation Journal ·Seng Chan You, Sung-Jae Jung, Joel N. Swerdel, Patrick Ryan, Martijn J. Schuemie, Marc A. Suchard, (unknown), Jaehyeong Cho, George Hripcsak, Rae Woong Park, Sungha Park	15
13	PheValuator: Development and evaluation of a phenotype algorithm evaluator 2019 ·Journal of Biomedical Informatics ·Joel N. Swerdel, George Hripcsak, Patrick Ryan	33
14	Work-Related Unintentional Injuries Associated With Hurricane Sandy in New Jersey 2016 ·Disaster Medicine and Public Health Preparedness ·Elizabeth G. Marshall, Shou‐En Lu, (unknown), Joel N. Swerdel, Marija Borjan, (unknown)	11
15	Association Between Dehydration and Short-Term Risk of Ischemic Stroke in Patients with Atrial Fibrillation 2016 ·Translational Stroke Research ·(unknown), Joel N. Swerdel, Teresa Janević, William J. Kostis, Ambarina S. Faiz, Nora M. Cosgrove, John B. Kostis	20
16	Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis) 2016 ·The American Journal of Cardiology ·Abel E. Moreyra, (unknown), Hui Gu, Joel N. Swerdel, James S. McKinney, Nora M. Cosgrove, William J. Kostis, John B. Kostis	9
17	Antihypertensive Activity During Inhibition of Neutral Endopeptidase and Angiotensin Converting Enzyme 1991 ·Journal of Cardiovascular Pharmacology ·Andrea A. Seymour, Joel N. Swerdel, Benoni E. Abboa‐Offei	75
18	Renal and Depressor Effects of SQ 29,072, a Neutral Endopeptidase Inhibitor, in Conscious Hypertensive Rats 1990 ·Journal of Cardiovascular Pharmacology ·Andrea A. Seymour, Jon Norman, Magdi M. Asaad, (unknown), Joel N. Swerdel, (unknown), Charles R. Dorso	21
19	Potentiation of the Depressor Responses to Atrial Natriuretic Peptides in Conscious SHR by an Inhibitor of Neutral Endopeptidase 1989 ·Journal of Cardiovascular Pharmacology ·Andrea A. Seymour, Joel N. Swerdel, (unknown), (unknown), (unknown), Norma G. Delaney	23
20	Atrial natriuretic peptides cleaved by endopeptidase are inactive in conscious spontaneously hypertensive rats 1988 ·Life Sciences ·Andrea A. Seymour, Joel N. Swerdel, (unknown), Norma G. Delaney	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact